Klinische Ökonomik – Was sie ist, was sie will und weshalb wir sie brauchen

Die klinische Ökonomik lässt sich einordnen zwischen den Kernfächern der Medizin und der Epidemiologie, der Ethik, den Wirtschaftswissenschaften und der Jurisprudenz. Durch die klinische Ökonomik wird eine Reihe bisher unbeachteter ethischer Konflikte aufgedeckt, von deren Lösung letztlich die Autonomie des Fachs Medizin abhängen wird.

• Literatur

• 1 Sackett DL, Richardson WS, Rosenberg W. et al. Evidence-based Medicine. First Edition. New York: Churchill Livingstone; 1997
• 2 Porzsolt F. Klinische Ökonomik: Die ökonomische Bewertung von Gesundheitsleistungen aus der Sicht des Patienten. In: Porzsolt F, Williams AR, Kaplan RM. (eds) Klinische Ökonomik. Effektivität und Effizienz von Gesundheitsleistungen. Ecomed Verlagsgesellschaft; 2003: 17-40
• 3 Porzsolt F, Kaplan RM. „CLINECS“: Strategy and Tactics to provide Evidence of the Usefulness of Health Care Services from the Patient’s Perspective (Value for Patients). In: Porzsolt F, Kaplan RM. (eds.) Optimizing Health – Improving the Value of Healthcare Delivery. New York: Springer; 2006. pp 1–9
• 4 Porzsolt F. Die wesentlichen Unterschiede zwischen Klinischer Ökonomik und Gesundheitsökonomie. In: Porzsolt F. (Hrsg.) Grundlagen der Klinischen Ökonomik. Schriftenreihe PVS Verband Band 11, 1.Auflage. Berlin: 2011: 17-21
• 5 Porzsolt F, Braubach P, Flurschütz PI. et al. Medical Students Help Avoid the Expert Bias in Medicine. Creative Education 2012; 03: 1115-1121
• 6 Porzsolt F, Bonotto de O, Costa IC, Thomaz TG. for the SHUFFLE group Advantages and Limitations of Twin Assessment of Clinical Trials (TACT). J Publ Health 2009; 17: 425-435
• 7 Rosati P, Porzsolt F. A practical educational tool for teaching child-care hospital professionals attending evidence-based practice courses for con-tinuing medical education to appraise internal validity in systematic re-views. J Eval Clin Pract 2013; 4: 648-652
• 8 Rosati P, Porzsolt F, Ricciotti G. et al. Major discrepancies between what clinical trial registries record and paediatric randomised controlled trials publish. Trials 2016; 17: 430-430
• 9 Porzsolt F, Eisemann M, Habs M. et al. Form Follows Function: Pragmatic Controlled Trials (PCTs) have to answer different questions and require different designs than Randomized Controlled Trials (RCTs). J Publ Health 2013; 21: 307-313
• 10 Haynes B. Can it work? Does it work? Is it worth it?. BMJ 1999; 319: 652 B-652 B
• 11 Roland M, Torgersen DJ. Understanding controlled trials. What are pragmatic trials?. Br Med J 1998; 316: 285-285
• 12 Porzsolt F, Rocha NG, Toledo-Arruda AC. et al. Efficacy and Effectiveness Trials Have Different Goals, Use Different Tools, and Generate Different Messages. Pragmatic and Observational Research 2015; 6: 47-54
• 13 Ioannidis JPA. Why Most Discovered True Associations Are Inflated. Epidemiology 2008; 19: 640-648
• 14 Ioannidis JPA. Why Most Clinical Research Is Not Useful. PLoS Med 2016 13. e1002049
• 15 Allison DB, Brown AW, Brandon JG. et al. A tragedy of errors. Mistakes in peer-reviewd papers are easy to find but hard to fix. Nature 2016; 530: 27-29
• 16 Bauer K, Schroeder M, Porzsolt F. et al. Comparison of international guidelines on the accompaning therapies for gastric cancer. Reasons for the differences. J Gastric Cancer 2015; 15: 10-18
• 17 Porzsolt F. Prostatakrebs-Studie. Keine Schuldzuweisungen. Dtsch Ärztebl 2017; 114: A228-229
• 18 Correia LC, Latado A, Porzsolt F. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2016; 375: 1797-1799
• 19 Berwick DM. Avoiding overuse—the next quality frontier. The Lancet published 08 January 2017
• 20 Brownlee S, Chalkidou K, Doust J. et al. Evidence for overuse of medical services around the world. The Lancet published 08 January 2017
• 21 Porzsolt F. The Y-nurse – pain in the neck or blessing for the team. BMJ blog by BMJ group, December 29, 2010
• 22 Porzsolt F. Clinical Economics and Nursing. Rev. Latino-Am.. Enfermagem 2015 23. Online version ISSN 1518–8345
• 23 Porzsolt F, Müller H, François-Kettner H. et al. The risk of safety in health care. J Med Safety 2014; 8-12
• 24 Porzsolt F. Prävention aus Sicht der Klinischen Ökonomik – Eine lebensnotwendige Konsequenz der Zivilisation oder „gefühlte Sicherheit“?. In: Kirch W, Middeke M, Rychlik R. (Hrsg) Aspekte der Prävention. Stuttgart: Thieme; 2010: 46-55
• 25 Porzsolt F, Polianski I, Görgen A. et al. Safety and security: the valences of values. Journal of Applied Security Research 2011; 6: 483-490
• 26 Porzsolt F. Evidence-based Risk Management: safety means “perception of risk”. 4th World Congress on Clinical Safety. Vienna/Austria: Sept 28–30, 2015
• 27 Porzsolt F. Safety means perception of risk. J Med Safety 2016; 18-24
• 28 Porzsolt F. Risk Management in Health Care – Lessons learned from Clinical Economics. In: Huber M, Moormann C, Proske D. Proceedings of the 10th International Probabilistic Workshop. Stuttgart: 2012